AU2001236909A1 - Method of treating disorders of the eye - Google Patents
Method of treating disorders of the eyeInfo
- Publication number
- AU2001236909A1 AU2001236909A1 AU2001236909A AU3690901A AU2001236909A1 AU 2001236909 A1 AU2001236909 A1 AU 2001236909A1 AU 2001236909 A AU2001236909 A AU 2001236909A AU 3690901 A AU3690901 A AU 3690901A AU 2001236909 A1 AU2001236909 A1 AU 2001236909A1
- Authority
- AU
- Australia
- Prior art keywords
- eye
- treating disorders
- disorders
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70546—Integrin superfamily, e.g. VLAs, leuCAM, GPIIb/GPIIIa, LPAM
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18186900P | 2000-02-11 | 2000-02-11 | |
US60/181,869 | 2000-02-11 | ||
PCT/US2001/004437 WO2001058931A1 (en) | 2000-02-11 | 2001-02-12 | Method of treating disorders of the eye |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001236909A1 true AU2001236909A1 (en) | 2001-08-20 |
Family
ID=22666147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001236909A Abandoned AU2001236909A1 (en) | 2000-02-11 | 2001-02-12 | Method of treating disorders of the eye |
Country Status (4)
Country | Link |
---|---|
US (1) | US20010053766A1 (en) |
EP (1) | EP1257566A4 (en) |
AU (1) | AU2001236909A1 (en) |
WO (1) | WO2001058931A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1551399A4 (en) * | 2002-09-30 | 2011-01-05 | Mark A Babizhayev | Method for topical treatment of eye disease and composition and device for said treatment |
US20040167076A1 (en) * | 2003-02-14 | 2004-08-26 | Stamer W. Daniel | Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in schlemm's canal cells |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5041450A (en) * | 1988-06-29 | 1991-08-20 | Research Corporation Technologies, Inc. | Treatment of ocular inflammation |
US5683867A (en) * | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
ATE179074T1 (en) * | 1991-11-07 | 1999-05-15 | Univ Southern California | COMPOSITIONS AND METHODS FOR PREVENTING ADHESION FORMATION |
US5536814A (en) * | 1993-09-27 | 1996-07-16 | La Jolla Cancer Research Foundation | Integrin-binding peptides |
US5753230A (en) * | 1994-03-18 | 1998-05-19 | The Scripps Research Institute | Methods and compositions useful for inhibition of angiogenesis |
DE19534016A1 (en) * | 1995-09-14 | 1997-03-20 | Merck Patent Gmbh | Biotin derivatives |
JPH1017488A (en) * | 1996-06-25 | 1998-01-20 | Asahi Glass Co Ltd | Glaucoma treating agent |
US5900414A (en) * | 1996-08-29 | 1999-05-04 | Merck & Co., Inc. | Methods for administering integrin receptor antagonists |
-
2001
- 2001-02-12 WO PCT/US2001/004437 patent/WO2001058931A1/en not_active Application Discontinuation
- 2001-02-12 AU AU2001236909A patent/AU2001236909A1/en not_active Abandoned
- 2001-02-12 US US09/780,612 patent/US20010053766A1/en not_active Abandoned
- 2001-02-12 EP EP01909124A patent/EP1257566A4/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1257566A1 (en) | 2002-11-20 |
EP1257566A4 (en) | 2005-06-15 |
WO2001058931A1 (en) | 2001-08-16 |
US20010053766A1 (en) | 2001-12-20 |
WO2001058931A9 (en) | 2002-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001269799A1 (en) | Methods for treating various eye disorders | |
AU2001249881A1 (en) | Method of treating the heart | |
AU7316601A (en) | Methods for treating inflammation-mediated conditions of the eye | |
AU2001288628A1 (en) | Method and reagents for treatment of skin disorders by modulating the notch pathway | |
AU2002215125A1 (en) | Well treatment method | |
AU2003210597A1 (en) | Methods for treating eye disorders | |
AU2001294794A1 (en) | Method and apparatus for spectrophotometry of the eye | |
AU3977700A (en) | Method of treating neurological disorders | |
AU2001286983A1 (en) | Method of treatment | |
ZA200003768B (en) | Methods and compositions for treating diseases and conditions of the eye. | |
AU2001237939A1 (en) | Methods for treating glaucoma | |
MXPA03003741A (en) | Methods and compositions for the treatment of diseases of the eye. | |
AU4552200A (en) | Method of treating psychotic disorders | |
AU2002241670A1 (en) | Method for treating glaucoma IB | |
AU2002320352A1 (en) | Methods for treating or preventing sclerotic disorders using cd2-binding agents | |
AU2001288792A1 (en) | Method of treating neurologic disorders | |
AU3757300A (en) | Method of treating anxiety disorders | |
AU1133901A (en) | Method of treating metabolic disorders | |
AU2002258798A1 (en) | Methods for the treatment of hepatic disorders | |
AU2001292705A1 (en) | Method of treating gastrointestinal disorders, particularly colitis | |
AU2001262177A1 (en) | Method of treatment | |
AU2001236909A1 (en) | Method of treating disorders of the eye | |
AU3753500A (en) | Methods of treating fibrinogen-related disorders | |
PL367097A1 (en) | Method of treating dry eye disorders | |
AU2002229795A1 (en) | Method for treating sexual disorders |